Harbor Capital Advisors Inc. lowered its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 8.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.

Piper Sandler Companies (NYSE:PIPR – Get Free Report)’s stock price was down 1.4% during trading on Tuesday . The stock traded as low as $293.09 and last traded at $297.24. Approximately 150,516 shares changed hands during mid-day trading,

On Wednesday, Dutch Bros Inc (BROS) stock saw a decline, ending the day at $58.89 which represents a decrease of $-0.19 or -0.32% from the prior close of $59.08. The stock opened at $60 and touched a low of $58.31 during the day, reaching a high of $60.57. The volume of shares traded was 3.06 million exceeding the average volume of 2.81 million.

CF Industries Holdings, Inc. (CF) stock saw a modest uptick, ending the day at $96.37 which represents a slight increase of $1.38 or 1.45% from the prior close of $94.99. The stock opened at $95.1 and touched a low of $94.

View Piper Sandler Companies (PIPR) current and estimated P/E ratio data provided by Seeking Alpha.

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the healthcare investment banking team. Kerins will ...

LONDON, January 06, 2025--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to ...

Piper Sandler lowered the firm’s price target on MarketAxess (MKTX) to $240 from $265 and keeps a Neutral rating on the shares as part of an earnings preview note for earnings, trading companies ...

Fintel reports that on January 6, 2025, Goldman Sachs downgraded their outlook for Piper Sandler Companies (NYSE:PIPR) from Buy to Neutral. Analyst Price Forecast Suggests 25.14% Upside As of December 23,

NEW YORK, January 13, 2025--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a

ChampionX Corp (CHX) stock saw a modest uptick, ending the day at $28.2 which represents a slight increase of $0.04 or 0.14% from the prior close of $28.16. The stock opened at $28.06 and touched a low of $27.